New registry tracks brain ablation device for Tough-to-Treat epilepsy
NCT ID NCT07546253
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study will collect real-world data from 100 people with drug-resistant epilepsy who receive or are considered for a procedure using the OneRF Ablation System. The system uses radiofrequency energy to target and destroy small areas of brain tissue causing seizures. Researchers will track seizure control, medication changes, and device safety over time.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this registry could provide real-world evidence on how well the OneRF Ablation System controls seizures in people with drug-resistant epilepsy.
- What could go wrong
- This is an observational registry, not a controlled trial, so results may be influenced by patient selection or other treatments. It is not designed to prove the device works better than alternatives.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG-RESISTANT EPILEPSY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a High-Fat diet and therapy tame seizures in rare childhood epilepsy?
- Zapping the brain without surgery: a new hope for Tough-to-Treat epilepsy
- Nerve block may cut opioid needs after epilepsy device surgery
- Sound waves aimed at the brain could quiet seizures
- Glowing dye could help surgeons spot hidden epilepsy lesions
- Brain scans may replace invasive electrodes for epilepsy surgery planning